Tert-Butylamine → HCID 66661260, compound
Reaction equation
[F:1][C:2]([F:7])([F:6])[C:3]([OH:5])=[O:4].[CH:8]1([NH:12][C:13](=[O:38])[NH:14][C:15]2[CH:37]=[CH:36][C:18]([C:19]([N:21]3[CH2:26][CH2:25][N:24]([CH2:27][C:28]4[O:29][CH:30]=[C:31]([C:33]([OH:35])=O)[N:32]=4)[CH2:23][CH2:22]3)=[O:20])=[CH:17][CH:16]=2)[CH2:11][CH2:10][CH2:9]1.[C:39]([NH2:43])([CH3:42])([CH3:41])[CH3:40].C(N(CC)C(C)C)(C)C>CN(C)C(=O)C>[F:1][C:2]([F:7])([F:6])[C:3]([OH:5])=[O:4].[C:39]([NH:43][C:33]([C:31]1[N:32]=[C:28]([CH2:27][N:24]2[CH2:25][CH2:26][N:21]([C:19]([C:18]3[CH:36]=[CH:37][C:15]([NH:14][C:13]([NH:12][CH:8]4[CH2:9][CH2:10][CH2:11]4)=[O:38])=[CH:16][CH:17]=3)=[O:20])[CH2:22][CH2:23]2)[O:29][CH:30]=1)=[O:35])([CH3:42])([CH3:41])[CH3:40]Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of 2-((4-(4-(3-cyclobutylureido)benzoyl)piperazin-1-yl)methyl)-oxazole-4-carboxylic acid 2,2,2-trifluoroacetate (8 mg, 15 μmol) in N,N-dimethyl-acetamide (1 mL) was added O-(7-azabenzotriazol-1-yl)-N,N,N,N-tetramethyl uronium hexafluorophosphate (5.7 mg, 154 μmol; HATU), tert-butylamine (1.6 μL, 15 μmol) and N,N-diisopropylethylamine (3.9 μL, 23 μmol). The reaction mixture was stirred at room temperature for 20 hours and was then concentrated under vacuum. The crude residue was purified by acidic reverse phase HPLC to give the title compound (5.6 mg). MS (ESI) m/z 483.1 [M+H]+
Workup
- concentrationwas then concentrated under vacuum
- customThe crude residue was purified by acidic reverse phase HPLC
Sources & evidence
- ORD record
- ord-f496a1c6cf7d4eb79df1a7993a743240
- Source dataset
- uspto-grants-2014_06
- Patent number
- US08759352B2
Reaction notes
Loading…